News | June 23, 2023
LVPEI raises awareness on antimicrobial resistance among medical students
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
The investment is part of Croda’s continuing commitment to develop high performance pharmaceutical ingredients and technologies for life sciences.
This trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
The slogan for this year's World Blood Donor Day campaign is 'Give blood, give plasma, share life, share often'
Application being reviewed under the FDA Project Orbis framework, which enables concurrent reviews among US, Australia, Canada, Switzerland, Singapore and United Kingdom health authorities
Lantern is receiving an exclusive and worldwide option to license intellectual property from Bielefeld University related to the collaboration and IP generated from the collaboration
Construction will begin this year with the new capacity anticipated by 2025
Acuitas Therapeutics' LNP technology will support Bayer’s in vivo gene editing and protein replacement programs with the goal of specifically delivering RNA payloads to the desired target organ, the liver.
Establishes distribution center in top hub for international shipping
Subscribe To Our Newsletter & Stay Updated
